Skip to main content

Table 2 Type of newly prescribed treatment and reason for GP consultation among colorectal cancer and matched cancer-free controls in the 6 months before index date, stratified by tumour site

From: A steep increase in healthcare seeking behaviour in the last months before colorectal cancer diagnosis

 

Proximal

Distal

Rectum

Cases

Cancer-free controls

Cases

Cancer-free controls

Cases

Cancer-free controls

N = 1,910

n (%)

N = 7,640

n (%)

N = 2,022

n (%)

N = 8,088

n (%)

N = 1,926

n (%)

N = 7,704

n (%)

Common newly prescribed medication

A06AD

  Osmotically acting laxatives

729 (38)

175 (2)

928 (46)

194 (2)

914 (48)

173 (2)

A06AB

  Contact laxatives

260 (14)

32 (< 0.5)

426 (21)

47 (1)

444 (23)

36 (1)

A02BC

  Proton pump inhibitors

288 (15)

373 (5)

182 (9)

377 (5)

143 (7)

337 (4)

B03AA

  Iron bivalent, oral preparations

273 (14)

32 (< 0.5)

71 (4)

42 (1)

31 (2)

25 (< 0.5)

A06AG

  Enemas

40 (2)

22 (< 0.5)

117 (6)

35 (< 0.5)

50 (3)

23 (< 0.5)

M01AB

  Acetic acid derivatives and related substances

116 (6)

303 (4)

106 (5)

300 (4)

76 (4)

323 (4)

Common reason for GP consultation

D75

  Malignant neoplasm colon/rectum

664 (35)

1 (< 0.5)

780 (39)

2 (< 0.5)

860 (45)

0 (0)

D16

  Rectal bleeding

10 (1)

13 (< 0.5)

94 (5)

11 (< 0.5)

78 (4)

12 (< 0.5)

B80

  Iron deficiency anaemia

99 (5)

9 (< 0.5)

27 (1)

10 (< 0.5)

15 (1)

2 (< 0.5)

B82

  Anaemia other/unspecified

64 (3)

11 (< 0.5)

12 (1)

10 (< 0.5)

9 (1)

12 (< 0.5)

D06

  Abdominal pain localized other

44 (2)

21 (< 0.5)

41 (2)

37 (1)

9 (1)

14 (< 0.5)